サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：非オピオイド疼痛パッチの世界市場 - 成長、将来展望、競合分析（2022年～2030年）
市場調査レポート
商品コード
1180700

非オピオイド疼痛パッチの世界市場 - 成長、将来展望、競合分析（2022年～2030年）

Non-Opioid Pain Patch Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日: | 発行: Acute Market Reports | ページ情報: 英文 120 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
非オピオイド疼痛パッチの世界市場 - 成長、将来展望、競合分析（2022年～2030年）
出版日: 2022年08月01日
発行: Acute Market Reports
ページ情報: 英文 120 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の非オピオイド疼痛パッチの市場は、オピオイドの有害な副作用や、慢性疼痛の増加傾向などによって促進されています。一方で、医薬品と比較して非オピオイド鎮痛剤の普及率が低いことが、市場の成長課題となっています。

当レポートでは、世界の非オピオイド疼痛パッチ市場を調査しており、市場の概要、市場分析、パッチ別・流通チャネル別・地域別の分析、競合情勢、および企業プロファイルなど包括的な情報を提供しています。

目次

第1章 序文

  • レポートの説明
    • レポートの目的
    • 対象者
    • 主な製品
  • 市場セグメンテーション
  • 調査手法
    • フェーズI - 2次調査
    • フェーズII - 1次調査
    • フェーズIII - 専門家による審査
    • 前提条件
    • 採用されたアプローチ

第2章 エグゼクティブサマリー

  • 市場スナップショット：世界の非オピオイド疼痛パッチ市場
  • 世界の非オピオイド疼痛パッチ市場、パッチ別、2021年
  • 世界の非オピオイド疼痛パッチ市場、流通チャネル別、2021年
  • 世界の非オピオイド疼痛パッチ市場、地域別、2021年
  • 魅力的な投資提案、地域別、2021年

第3章 非オピオイド疼痛パッチ市場：競合分析

  • 主要な非オピオイド疼痛パッチ市場ベンダーの市場ポジショニング
  • 非オピオイド疼痛パッチ市場ベンダーが採用する戦略
  • 主要な業界戦略
  • ティア分析、2021年対2030年

第4章 非オピオイド疼痛パッチ市場：マクロ分析と市場力学

  • イントロダクション
  • 世界の非オピオイド疼痛パッチの市場金額（2020年～2030年）
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因と抑制要因の影響分析
  • シーソー分析

第5章 非オピオイド疼痛パッチ市場：パッチ別（2020年～2030年）

  • 市場概要
  • 成長と収益分析：2021年対2030年
  • 市場セグメンテーション
    • リドカインパッチ
    • ジクロフェナクパッチ
    • カプサイシンパッチ
    • サリチル酸メチルパッチ
    • その他

第6章 非オピオイド疼痛パッチ市場：流通チャネル別（2020年～2030年）

  • 市場概要
  • 成長と収益分析：2021年対2030年
  • 市場セグメンテーション
    • 病院薬局
    • 小売薬局/個人薬局
    • Eコマース/オンライン薬局

第7章 北米の非オピオイド疼痛パッチ市場（2020年～2030年）

  • 市場概要
  • 非オピオイド疼痛パッチ市場：パッチ別（2020年～2030年）
  • 非オピオイド疼痛パッチ市場：流通チャネル別（2020年～2030年）
  • 非オピオイド疼痛パッチ市場：地域別（2020年～2030年）
    • 北米

第8章 英国・欧州連合の非オピオイド疼痛パッチ市場（2020年～2030年）

  • 市場概要
  • 非オピオイド疼痛パッチ市場：パッチ別（2020年～2030年）
  • 非オピオイド疼痛パッチ市場：流通チャネル別（2020年～2030年）
  • 非オピオイド疼痛パッチ市場：地域別（2020年～2030年）
    • 英国・欧州連合

第9章 アジア太平洋の非オピオイド疼痛パッチ市場（2020年～2030年）

  • 市場概要
  • 非オピオイド疼痛パッチ市場：パッチ別（2020年～2030年）
  • 非オピオイド疼痛パッチ市場：流通チャネル別（2020年～2030年）
  • 非オピオイド疼痛パッチ市場：地域別（2020年～2030年）
    • アジア太平洋

第10章 ラテンアメリカの非オピオイド疼痛パッチ市場（2020年～2030年）

  • 市場概要
  • 非オピオイド疼痛パッチ市場：パッチ別（2020年～2030年）
  • 非オピオイド疼痛パッチ市場：流通チャネル別（2020年～2030年）
  • 非オピオイド疼痛パッチ市場：地域別（2020年～2030年）
    • ラテンアメリカ

第11章 中東・アフリカの非オピオイド疼痛パッチ市場（2020年～2030年）

  • 市場概要
  • 非オピオイド疼痛パッチ市場：パッチ別（2020年～2030年）
  • 非オピオイド疼痛パッチ市場：流通チャネル別（2020年～2030年）
  • 非オピオイド疼痛パッチ市場：地域別（2020年～2030年）
    • 中東・アフリカ

第12章 企業プロファイル

  • Teh Seng Pharmaceutical Mfg. Co., Ltd.
  • Endo Pharmaceuticals Inc.
  • Teikoku Seiyaku Co.
  • Allergan
  • Pfizer, Inc.
  • Hisamitsu Pharmaceutical Co. Inc.
  • GlaxoSmithKline plc.
  • Mylan N.V.
  • IBSA Institut Biochimque SA, Inc.
  • Acorda Therapeutics
  • その他
図表

List of Tables

  • TABLE 1 Global Non-Opioid Pain Patch Market By Patch, 2020-2030, USD (Million)
  • TABLE 2 Global Non-Opioid Pain Patch Market By Distribution Channel, 2020-2030, USD (Million)
  • TABLE 3 North America Non-Opioid Pain Patch Market By Patch, 2020-2030, USD (Million)
  • TABLE 4 North America Non-Opioid Pain Patch Market By Distribution Channel, 2020-2030, USD (Million)
  • TABLE 5 U.S. Non-Opioid Pain Patch Market By Patch, 2020-2030, USD (Million)
  • TABLE 6 U.S. Non-Opioid Pain Patch Market By Distribution Channel, 2020-2030, USD (Million)
  • TABLE 7 Canada Non-Opioid Pain Patch Market By Patch, 2020-2030, USD (Million)
  • TABLE 8 Canada Non-Opioid Pain Patch Market By Distribution Channel, 2020-2030, USD (Million)
  • TABLE 9 Rest of North America Non-Opioid Pain Patch Market By Patch, 2020-2030, USD (Million)
  • TABLE 10 Rest of North America Non-Opioid Pain Patch Market By Distribution Channel, 2020-2030, USD (Million)
  • TABLE 11 UK and European Union Non-Opioid Pain Patch Market By Patch, 2020-2030, USD (Million)
  • TABLE 12 UK and European Union Non-Opioid Pain Patch Market By Distribution Channel, 2020-2030, USD (Million)
  • TABLE 13 UK Non-Opioid Pain Patch Market By Patch, 2020-2030, USD (Million)
  • TABLE 14 UK Non-Opioid Pain Patch Market By Distribution Channel, 2020-2030, USD (Million)
  • TABLE 15 Germany Non-Opioid Pain Patch Market By Patch, 2020-2030, USD (Million)
  • TABLE 16 Germany Non-Opioid Pain Patch Market By Distribution Channel, 2020-2030, USD (Million)
  • TABLE 17 Spain Non-Opioid Pain Patch Market By Patch, 2020-2030, USD (Million)
  • TABLE 18 Spain Non-Opioid Pain Patch Market By Distribution Channel, 2020-2030, USD (Million)
  • TABLE 19 Italy Non-Opioid Pain Patch Market By Patch, 2020-2030, USD (Million)
  • TABLE 20 Italy Non-Opioid Pain Patch Market By Distribution Channel, 2020-2030, USD (Million)
  • TABLE 21 France Non-Opioid Pain Patch Market By Patch, 2020-2030, USD (Million)
  • TABLE 22 France Non-Opioid Pain Patch Market By Distribution Channel, 2020-2030, USD (Million)
  • TABLE 23 Rest of Europe Non-Opioid Pain Patch Market By Patch, 2020-2030, USD (Million)
  • TABLE 24 Rest of Europe Non-Opioid Pain Patch Market By Distribution Channel, 2020-2030, USD (Million)
  • TABLE 25 Asia Non-Opioid Pain Patch Market By Patch, 2020-2030, USD (Million)
  • TABLE 26 Asia Non-Opioid Pain Patch Market By Distribution Channel, 2020-2030, USD (Million)
  • TABLE 27 China Non-Opioid Pain Patch Market By Patch, 2020-2030, USD (Million)
  • TABLE 28 China Non-Opioid Pain Patch Market By Distribution Channel, 2020-2030, USD (Million)
  • TABLE 29 Japan Non-Opioid Pain Patch Market By Patch, 2020-2030, USD (Million)
  • TABLE 30 Japan Non-Opioid Pain Patch Market By Distribution Channel, 2020-2030, USD (Million)
  • TABLE 31 India Non-Opioid Pain Patch Market By Patch, 2020-2030, USD (Million)
  • TABLE 32 India Non-Opioid Pain Patch Market By Distribution Channel, 2020-2030, USD (Million)
  • TABLE 33 Australia Non-Opioid Pain Patch Market By Patch, 2020-2030, USD (Million)
  • TABLE 34 Australia Non-Opioid Pain Patch Market By Distribution Channel, 2020-2030, USD (Million)
  • TABLE 35 South Korea Non-Opioid Pain Patch Market By Patch, 2020-2030, USD (Million)
  • TABLE 36 South Korea Non-Opioid Pain Patch Market By Distribution Channel, 2020-2030, USD (Million)
  • TABLE 37 Latin America Non-Opioid Pain Patch Market By Patch, 2020-2030, USD (Million)
  • TABLE 38 Latin America Non-Opioid Pain Patch Market By Distribution Channel, 2020-2030, USD (Million)
  • TABLE 39 Brazil Non-Opioid Pain Patch Market By Patch, 2020-2030, USD (Million)
  • TABLE 40 Brazil Non-Opioid Pain Patch Market By Distribution Channel, 2020-2030, USD (Million)
  • TABLE 41 Mexico Non-Opioid Pain Patch Market By Patch, 2020-2030, USD (Million)
  • TABLE 42 Mexico Non-Opioid Pain Patch Market By Distribution Channel, 2020-2030, USD (Million)
  • TABLE 43 Rest of Latin America Non-Opioid Pain Patch Market By Patch, 2020-2030, USD (Million)
  • TABLE 44 Rest of Latin America Non-Opioid Pain Patch Market By Distribution Channel, 2020-2030, USD (Million)
  • TABLE 45 Middle East and Africa Non-Opioid Pain Patch Market By Patch, 2020-2030, USD (Million)
  • TABLE 46 Middle East and Africa Non-Opioid Pain Patch Market By Distribution Channel, 2020-2030, USD (Million)
  • TABLE 47 GCC Non-Opioid Pain Patch Market By Patch, 2020-2030, USD (Million)
  • TABLE 48 GCC Non-Opioid Pain Patch Market By Distribution Channel, 2020-2030, USD (Million)
  • TABLE 49 Africa Non-Opioid Pain Patch Market By Patch, 2020-2030, USD (Million)
  • TABLE 50 Africa Non-Opioid Pain Patch Market By Distribution Channel, 2020-2030, USD (Million)
  • TABLE 51 Rest of Middle East and Africa Non-Opioid Pain Patch Market By Patch, 2020-2030, USD (Million)
  • TABLE 52 Rest of Middle East and Africa Non-Opioid Pain Patch Market By Distribution Channel, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Non-Opioid Pain Patch Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Non-Opioid Pain Patch Market: Quality Assurance
  • FIG. 5 Global Non-Opioid Pain Patch Market, By Patch, 2021
  • FIG. 6 Global Non-Opioid Pain Patch Market, By Distribution Channel, 2021
  • FIG. 7 Global Non-Opioid Pain Patch Market, By Geography, 2021
  • FIG. 8 Market Geographical Opportunity Matrix - Global Non-Opioid Pain Patch Market, 2021
  • FIG. 9 Market Positioning of Key Non-Opioid Pain Patch Market Players, 2021
  • FIG. 10 Global Non-Opioid Pain Patch Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
  • FIG. 11 Global Non-Opioid Pain Patch Market, By Patch, 2021 Vs 2030, %
  • FIG. 12 Global Non-Opioid Pain Patch Market, By Distribution Channel, 2021 Vs 2030, %
  • FIG. 13 U.S. Non-Opioid Pain Patch Market (US$ Million), 2020 - 2030
  • FIG. 14 Canada Non-Opioid Pain Patch Market (US$ Million), 2020 - 2030
  • FIG. 15 Rest of North America Non-Opioid Pain Patch Market (US$ Million), 2020 - 2030
  • FIG. 16 UK Non-Opioid Pain Patch Market (US$ Million), 2020 - 2030
  • FIG. 17 Germany Non-Opioid Pain Patch Market (US$ Million), 2020 - 2030
  • FIG. 18 Spain Non-Opioid Pain Patch Market (US$ Million), 2020 - 2030
  • FIG. 19 Italy Non-Opioid Pain Patch Market (US$ Million), 2020 - 2030
  • FIG. 20 France Non-Opioid Pain Patch Market (US$ Million), 2020 - 2030
  • FIG. 21 Rest of Europe Non-Opioid Pain Patch Market (US$ Million), 2020 - 2030
  • FIG. 22 China Non-Opioid Pain Patch Market (US$ Million), 2020 - 2030
  • FIG. 23 Japan Non-Opioid Pain Patch Market (US$ Million), 2020 - 2030
  • FIG. 24 India Non-Opioid Pain Patch Market (US$ Million), 2020 - 2030
  • FIG. 25 Australia Non-Opioid Pain Patch Market (US$ Million), 2020 - 2030
  • FIG. 26 South Korea Non-Opioid Pain Patch Market (US$ Million), 2020 - 2030
  • FIG. 27 Rest of Asia Non-Opioid Pain Patch Market (US$ Million), 2020 - 2030
  • FIG. 28 Brazil Non-Opioid Pain Patch Market (US$ Million), 2020 - 2030
  • FIG. 29 Mexico Non-Opioid Pain Patch Market (US$ Million), 2020 - 2030
  • FIG. 30 Rest of Latin America Non-Opioid Pain Patch Market (US$ Million), 2020 - 2030
  • FIG. 31 GCC Non-Opioid Pain Patch Market (US$ Million), 2020 - 2030
  • FIG. 32 Africa Non-Opioid Pain Patch Market (US$ Million), 2020 - 2030
  • FIG. 33 Rest of Middle East and Africa Non-Opioid Pain Patch Market (US$ Million), 2020 - 2030
目次
Product Code: 137687-08-22

Pain is a symptom, fundamentally results from any injury, infection, disorder or disease. Globally more than 1.5 billion people suffer from different types of pain and among all, lower back pain, neck pain, headache and facial pain are most common. Unlike acute pain which is temporary and relieved when underlying cause is healed, chronic pain in general lasts for longer period of time. Management of pain is accomplished with the various treatment by using drug therapy, physical therapy, biofeedback and other treatments.

The non-opioid pain patch is kind of a treatment for pain relief. The pain patch, when placed on painful area releases its medicine content through skin surface and inhibit the pain signal transfer. The patches can be customized as per the applied area. To counteract the opioid abuse, newer, innovative and more effective non-opioid pain patches are getting developed which in turn drive the non-opioid pain patch market growth.

Rising opioid abuse is the major concern as only in U.S. more than 20,000 death has been recorded resulting from opioid overdose. Along with, rising opioid abuse, the harmful side effects of opioids drive the usage of non-opioid pain patch and drive its market. The increasing trend of chronic pain contributes growth of the non-opioid pain patch market. The non-opioid pain patch market is still growing as many of its products are under clinical trial. Teikoku Pharma USA, Inc. declared their recent innovation dexmedetomidine transdermal non-opioid pain patch for post-surgical pain treatment which is still under clinical trial and expected to provide effective result in pain management. However, the lower adoption rate of non-opioid pain patch in contrast to drugs, poses some challenges to the growth of non-opioid pain patch market.

The purpose of this research study titled 'Non-Opioid Pain Patch Market - Growth, Future Prospects, and Competitive Analysis, 2022 - 2030' is to provide investors, developers, company executives and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global non-opioid pain patch market. This report presents and analyzes the major trends prevalent in the global non-opioid pain patch market and the market size and forecast.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global non-opioid pain patch market. Competition assessment tools such as, major agreements, partnerships and collaborations, market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the non-opioid pain patch market. The key players profiled in this report are Teh Seng Pharmaceutical Mfg. Co., Ltd., Endo Pharmaceuticals Inc., Teikoku Seiyaku Co., Ltd., Allergan, Pfizer, Inc., Hisamitsu Pharmaceutical Co. Inc., GlaxoSmithKline plc., Mylan N.V., IBSA Institut Biochimque SA, Inc., Acorda Therapeutics and others.

Transdermal drug delivery is the best alternative of oral drug delivery. This non-invasive procedure provides better patient outcome with lesser adverse effects.

Lidocaine patch is a non-opioid, applied to healthy skin. This patch is used to treat neuropathic pain generally from post-herpetic neuralgia and it is also useful for the treatment of diabetic neuropathy or HIV related neuropathy. Lidoderm was the first Lidocaine patch which received FDA approval. Lidocaine patch market is expected to be the largest and estimated to grow more in near future. The safety, fewer risk and lesser chances of side effects contribute to the growth of its market.

Methyl salicylate patch is used to treat the pain caused by arthritis, strain or sprain. Salonpas is the first and only FDA approved over-the-counter methyl salicylate pain patch. Capsaicin patches helps to resolve muscle or joint pains and Diclofenac patches work by blocking the pain producing agent for the treatment of pain from minor strain, bruise or injury.

Although there are some adverse effects associated with the non-opioid patches like allergic reaction, hives, redness, blisters, shortness of breathing etc. however benefits of customization of patches, easy administration, fewer doses, and better patient outcome attribute the growth of the non-opioid pain patch market.

The hospital pharmacy is predicted to contribute to the maximum growth of the non-opioid pain patch market, whereas the retail pharmacy and e-commerce are expected to face major growth in forecasting years due to extensive discount and easy availability of products. In case of online pharmacy, the option of free delivery draws the attention of public, hence expected to face lucrative growth in upcoming years.

The global non-opioid pain patch market regionally is cumulative to North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

North America is anticipated to dominate the non-opioid pain patch market followed by Europe. As per the study of National Institutes of Health's National Center for Complementary and Integrative Health (NCCIH), more than 50 million people in America suffer from chronic pain. Pain is a serious health issue globally, in which $560-635 Bn USD is spent annually for the treatment only in the U.S. This increasing incidence of severe pain along with the public health awareness attribute to the dominance of North American region. More than 2 million people substance abuse disorder using prescription opioids and around 20,000 people died from opioid overdose in 2015. This rate of opioid abuse shift the trend of pain management towards non-opioid pain patch. Research on innovative and effective product development for pain management drive the non-opioid pain patch market in North-America and European region. The prevalence of post-herpetic neuralgia is around 144,000 in U.S., and the associated pain is difficult to treat with oral drugs which drive more usage of Lidocaine patch and fuel its growth. The huge number of population suffering from pain disorders, developing healthcare infrastructure, cost-effectiveness fuel the growth of non-opioid pain patch market in Asia-Pacific region and it is expected to face substantial growth in upcoming periods due to the growing trend of health awareness in public.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Non-Opioid Pain Patch market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Non-Opioid Pain Patch market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Patch

Lidocaine Patches

Diclofenac Patches

Capsaicin Patches

Methyl Salicylate Patches

Others

Distribution Channel

Hospital Pharmacy

Retail Pharmacy/Independent Pharmacy

E-commerce/ Online Pharmacy

Region Segment (2020-2030; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of Covid-19 Segment (2020-2021; US$ Million )

Pre Covid-19 situation

Post Covid-19 situation

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Non-Opioid Pain Patch market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2030.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Non-Opioid Pain Patch market?

Which is the largest regional market for Non-Opioid Pain Patch market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Non-Opioid Pain Patch market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Non-Opioid Pain Patch market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Non-Opioid Pain Patch Market
  • 2.2. Global Non-Opioid Pain Patch Market, By Patch, 2021 (US$ Million)
  • 2.3. Global Non-Opioid Pain Patch Market, By Distribution Channel, 2021 (US$ Million)
  • 2.4. Global Non-Opioid Pain Patch Market, By Geography, 2021 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2021

3. Non-Opioid Pain Patch Market: Competitive Analysis

  • 3.1. Market Positioning of Key Non-Opioid Pain Patch Market Vendors
  • 3.2. Strategies Adopted by Non-Opioid Pain Patch Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2021 Versus 2030

4. Non-Opioid Pain Patch Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Non-Opioid Pain Patch Market Value, 2020 - 2030, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Non-Opioid Pain Patch Market: By Patch, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Lidocaine Patches
    • 5.3.2. Diclofenac Patches
    • 5.3.3. Capsaicin Patches
    • 5.3.4. Methyl Salicylate Patches
    • 5.3.5. Others

6. Non-Opioid Pain Patch Market: By Distribution Channel, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 6.3. Market Segmentation
    • 6.3.1. Hospital Pharmacy
    • 6.3.2. Retail Pharmacy/Independent Pharmacy
    • 6.3.3. E-commerce/ Online Pharmacy

7. North America Non-Opioid Pain Patch Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Non-Opioid Pain Patch Market: By Patch, 2020-2030, USD (Million)
  • 7.3. Non-Opioid Pain Patch Market: By Distribution Channel, 2020-2030, USD (Million)
  • 7.4.Non-Opioid Pain Patch Market: By Region, 2020-2030, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. Non-Opioid Pain Patch Market: By Patch, 2020-2030, USD (Million)
        • 7.4.1.1.1. Non-Opioid Pain Patch Market: By Distribution Channel, 2020-2030, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. Non-Opioid Pain Patch Market: By Patch, 2020-2030, USD (Million)
        • 7.4.1.2.1. Non-Opioid Pain Patch Market: By Distribution Channel, 2020-2030, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. Non-Opioid Pain Patch Market: By Patch, 2020-2030, USD (Million)
        • 7.4.1.3.1. Non-Opioid Pain Patch Market: By Distribution Channel, 2020-2030, USD (Million)

8. UK and European Union Non-Opioid Pain Patch Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Non-Opioid Pain Patch Market: By Patch, 2020-2030, USD (Million)
  • 8.3. Non-Opioid Pain Patch Market: By Distribution Channel, 2020-2030, USD (Million)
  • 8.4.Non-Opioid Pain Patch Market: By Region, 2020-2030, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. Non-Opioid Pain Patch Market: By Patch, 2020-2030, USD (Million)
        • 8.4.1.1.1. Non-Opioid Pain Patch Market: By Distribution Channel, 2020-2030, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. Non-Opioid Pain Patch Market: By Patch, 2020-2030, USD (Million)
        • 8.4.1.2.1. Non-Opioid Pain Patch Market: By Distribution Channel, 2020-2030, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. Non-Opioid Pain Patch Market: By Patch, 2020-2030, USD (Million)
        • 8.4.1.3.1. Non-Opioid Pain Patch Market: By Distribution Channel, 2020-2030, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. Non-Opioid Pain Patch Market: By Patch, 2020-2030, USD (Million)
        • 8.4.1.4.1. Non-Opioid Pain Patch Market: By Distribution Channel, 2020-2030, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. Non-Opioid Pain Patch Market: By Patch, 2020-2030, USD (Million)
        • 8.4.1.5.1. Non-Opioid Pain Patch Market: By Distribution Channel, 2020-2030, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. Non-Opioid Pain Patch Market: By Patch, 2020-2030, USD (Million)
        • 8.4.1.6.1. Non-Opioid Pain Patch Market: By Distribution Channel, 2020-2030, USD (Million)

9. Asia Pacific Non-Opioid Pain Patch Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Non-Opioid Pain Patch Market: By Patch, 2020-2030, USD (Million)
  • 9.3. Non-Opioid Pain Patch Market: By Distribution Channel, 2020-2030, USD (Million)
  • 9.4.Non-Opioid Pain Patch Market: By Region, 2020-2030, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. Non-Opioid Pain Patch Market: By Patch, 2020-2030, USD (Million)
        • 9.4.1.1.1. Non-Opioid Pain Patch Market: By Distribution Channel, 2020-2030, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. Non-Opioid Pain Patch Market: By Patch, 2020-2030, USD (Million)
        • 9.4.1.2.1. Non-Opioid Pain Patch Market: By Distribution Channel, 2020-2030, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. Non-Opioid Pain Patch Market: By Patch, 2020-2030, USD (Million)
        • 9.4.1.3.1. Non-Opioid Pain Patch Market: By Distribution Channel, 2020-2030, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. Non-Opioid Pain Patch Market: By Patch, 2020-2030, USD (Million)
        • 9.4.1.4.1. Non-Opioid Pain Patch Market: By Distribution Channel, 2020-2030, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. Non-Opioid Pain Patch Market: By Patch, 2020-2030, USD (Million)
        • 9.4.1.5.1. Non-Opioid Pain Patch Market: By Distribution Channel, 2020-2030, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. Non-Opioid Pain Patch Market: By Patch, 2020-2030, USD (Million)
        • 9.4.1.6.1. Non-Opioid Pain Patch Market: By Distribution Channel, 2020-2030, USD (Million)

10. Latin America Non-Opioid Pain Patch Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Non-Opioid Pain Patch Market: By Patch, 2020-2030, USD (Million)
  • 10.3. Non-Opioid Pain Patch Market: By Distribution Channel, 2020-2030, USD (Million)
  • 10.4.Non-Opioid Pain Patch Market: By Region, 2020-2030, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. Non-Opioid Pain Patch Market: By Patch, 2020-2030, USD (Million)
        • 10.4.1.1.1. Non-Opioid Pain Patch Market: By Distribution Channel, 2020-2030, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. Non-Opioid Pain Patch Market: By Patch, 2020-2030, USD (Million)
        • 10.4.1.2.1. Non-Opioid Pain Patch Market: By Distribution Channel, 2020-2030, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. Non-Opioid Pain Patch Market: By Patch, 2020-2030, USD (Million)
        • 10.4.1.3.1. Non-Opioid Pain Patch Market: By Distribution Channel, 2020-2030, USD (Million)

11. Middle East and Africa Non-Opioid Pain Patch Market, 2020-2030, USD (Million)

  • 11.1. Market Overview
  • 11.2. Non-Opioid Pain Patch Market: By Patch, 2020-2030, USD (Million)
  • 11.3. Non-Opioid Pain Patch Market: By Distribution Channel, 2020-2030, USD (Million)
  • 11.4.Non-Opioid Pain Patch Market: By Region, 2020-2030, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. Non-Opioid Pain Patch Market: By Patch, 2020-2030, USD (Million)
        • 11.4.1.1.1. Non-Opioid Pain Patch Market: By Distribution Channel, 2020-2030, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. Non-Opioid Pain Patch Market: By Patch, 2020-2030, USD (Million)
        • 11.4.1.2.1. Non-Opioid Pain Patch Market: By Distribution Channel, 2020-2030, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. Non-Opioid Pain Patch Market: By Patch, 2020-2030, USD (Million)
        • 11.4.1.3.1. Non-Opioid Pain Patch Market: By Distribution Channel, 2020-2030, USD (Million)

12. Company Profile

  • 12.1. Teh Seng Pharmaceutical Mfg. Co., Ltd.
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. Endo Pharmaceuticals Inc.
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. Teikoku Seiyaku Co.
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. Allergan
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. Pfizer, Inc.
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. Hisamitsu Pharmaceutical Co. Inc.
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. GlaxoSmithKline plc.
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. Mylan N.V.
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. IBSA Institut Biochimque SA, Inc.
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives
  • 12.10. Acorda Therapeutics
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Portfolio
    • 12.10.4. Strategic Initiatives
  • 12.11. Others
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Portfolio
    • 12.11.4. Strategic Initiatives